13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001779763
Total reported value
$874.7M
$874.7M
27 檔
25.1%
In Q2 2025, Iron Triangle Partners LP's U.S. equity holdings reached a combined market value of $874.7M, distributed across 27 disclosed stock positions.
During Q2 2025, Iron Triangle Partners LP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including CVS, CRL, ABBV) accounted for 25.1% of total reported equity market value during Q2 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CVS | Cvs Health CORP | Stock-Healthcare | 7.94% | -4.63% | — | |
| 2 | CRL | Charles River Laboratories | Stock-Healthcare | 7.46% | +2.70% | — | |
| 3 | ABBV | Abbvie Inc | Stock-Healthcare | 7.13% | -6.60% | EXIT | |
| 4 | MMSI | Merit Medical Systems Inc | Stock-Healthcare | 5.64% | +3.89% | NEW | |
| 5 | ICLR | ICON Public Limited Company | Stock-Healthcare | 5.58% | — | — | |
| 6 | MDT | Medtronic plc | Stock-Healthcare | 5.35% | -6.14% | EXIT | |
| 7 | THC | Tenet Healthcare CORP | Stock-Healthcare | 5.14% | -3.97% | EXIT | |
| 8 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 5.01% | +6.12% | NEW | |
| 9 | HCA | Hca Healthcare Inc | Stock-Healthcare | 4.71% | — | — | |
| 10 | DOCS | Doximity Inc-class A | Stock-Healthcare | 4.44% | +1.30% | +30.92% | |
| 11 | BTSG | Brightspring Health Services | Stock-Other | 4.35% | -1.37% | +66.13% | |
| 12 | GKOS | Glaukos CORP | Stock-Healthcare | 4.30% | -3.98% | EXIT | |
| 13 | PODD | Insulet CORP | Stock-Healthcare | 3.28% | — | -35.83% | |
| 14 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 2.96% | — | — | |
| 15 | AHCO | Adapthealth CORP | Stock-Other | 2.78% | +0.52% | +18.96% | |
| 16 | CAH | Cardinal Health Inc | Stock-Healthcare | 2.72% | -3.08% | EXIT | |
| 17 | ADPT | Adaptive Biotechnologies | Stock-Other | 2.68% | -3.87% | EXIT | |
| 18 | EXK | Exact Sciences CORP | Stock-Materials | 2.45% | -3.89% | EXIT | |
| 19 | TWST | Twist Bioscience CORP | Stock-Other | 2.40% | — | +0.10% | |
| 20 | GH | Guardant Health Inc | Stock-Healthcare | 2.40% | -3.55% | EXIT | |
| 21 | ONC | Beone Medicines Ltd-adr | Stock-Other | 2.23% | — | -38.68% | |
| 22 | NVST | Envista Holdings CORP | Stock-Healthcare | 1.86% | +2.95% | NEW | |
| 23 | BKD | Brookdale Senior Living Inc | Stock-Other | 1.82% | +0.89% | — | |
| 24 | EHABUSD | Enhabit Inc | Stock-Other | 1.52% | — | -9.83% | |
| 25 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.47% | — | -55.15% | |
| 26 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.32% | -1.04% | EXIT | |
| 27 | INSM | Insmed Inc | Stock-Healthcare | 1.08% | — | — |
According to official SEC Form 13F filings, Iron Triangle Partners LP reported a total U.S. public equity portfolio value of $874.7M across 27 disclosed positions in Q2 2025.
During Q2 2025, Iron Triangle Partners LP's top holdings by market value included CVS (7.9%)、CRL (7.5%)、ABBV (7.1%). The largest single position, CVS, represented 7.9% of total portfolio value.
In Q2 2025, Iron Triangle Partners LP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.